US-Based Custom Synthesis: A Capability Map

US-based custom synthesis capability is the thing every domestic CRO claims and very few buyers verify properly. The claim is cheap to make. Every supplier website carries the same list — cryogenics, hydrogenation, fluorination, chiral chemistry, flow — because those are the phrases buyers type into search. The list tells you almost nothing about whether your specific molecule will come out the other end on schedule.

The useful way to think about domestic capability is not by vendor but by chemistry type. Your route has three or four hard steps. Those steps require specific unit operations, at specific scales, with specific containment and temperature control. Whether a given supplier can deliver depends on whether they have the equipment for those operations, whether their chemists have actually run them, and whether those chemists are available in the window you need. Those are three separate questions and most buyers only ask the first.

This post is a map of the terrain. For each major capability area we cover what it is, when your molecule needs it, what to ask a supplier to prove they have it, and what a wrong answer costs you in weeks and dollars. It sits under our pharmaceutical supply chain de-risking framework, which covers the sourcing strategy this capability question sits inside.

How to Read a CRO’s Capability Claims

Read every capability claim as three separate assertions and verify each one independently: they own the equipment, their people have used it for chemistry like yours, and those people are free when you need them.

Equipment List Versus Demonstrated Experience

An equipment list is a purchase history. It tells you what was bought and, sometimes, what condition it is in. It does not tell you whether anyone in the building has run your reaction class in it. A 20-liter jacketed reactor with a minus 90 degrees Celsius chiller is a real asset, but if the group has only ever used it for cold crystallizations, your organolithium addition will be their first.

The question that separates the two is deliberately narrow: ‘What is the closest thing to this reaction that you have run in the last eighteen months, and at what scale?’ A supplier with genuine experience answers with a specific transformation, a scale, and usually an unprompted comment about what went wrong the first time. A supplier without it answers with a restatement of the equipment list. That difference is diagnostic and it takes one email to obtain.

The Staffing Question Nobody Asks

Capability lives in people. A CRO that ran excellent Buchwald chemistry three years ago may have lost the chemist who owned it. Equipment persists; tacit knowledge does not. Ask directly: who would run this project, how long have they been with the group, and what comparable work have they done. You are not asking for a resume — you are testing whether a named individual exists. If the answer is ‘our team,’ ask again.

Also ask what else that person is running in your window. Domestic capacity is genuinely tight in a few areas, and a supplier who is honest about queue position is more useful than one who promises a start date they will miss by five weeks.

Three Claims Worth Probing Hard

Claim as written	What it often means	What to ask
Cryogenic capability to −78 °C	A dry ice bath on a 5-liter flask	Reactor volume, internal temperature under load, longest documented hold
High-pressure hydrogenation	A 100 mL Parr shaker at 4 bar	Vessel volume, maximum rated pressure, hydrogen supply and area classification
Chiral synthesis and resolution	They have purchased chiral auxiliaries	Which approach, whose method, and whether preparative separation is in house

None of these are dishonest claims. They are true statements at a scale that may not be your scale. The failure mode is a buyer assuming the claim scales linearly, and finding out at kilogram stage that it does not.

Cryogenic Chemistry to −78 °C

Cryogenic chemistry means running reactions at temperatures low enough to control selectivity or suppress decomposition, conventionally down to minus 78 degrees Celsius, the sublimation point of solid carbon dioxide.

When Your Molecule Needs It

You need cryogenics when the route contains an organolithium or Grignard addition where warm conditions give the wrong regiochemistry, a directed ortho-metalation, a halogen-metal exchange, an enolate alkylation requiring kinetic control, or an unstable intermediate that must be trapped before it decomposes. Directed metalation on substituted heterocycles is the single most common trigger. If your route builds a substituted pyridine, indole or azine by deprotonating a specific ring position, you are in cryogenic territory.

Substrates from our heterocyclic compounds catalog illustrate the pattern. 4-Fluoroindole (CAS 387-43-9) is routinely functionalized by low-temperature metalation, where the fluorine acts as a directing group and warm conditions scramble the substitution pattern. Halogenated heterocycles such as 3-Iodopyridine (CAS 1120-90-7) undergo halogen-metal exchange that is clean at minus 78 degrees Celsius and messy at minus 40.

What to Ask a Supplier to Prove It

1. Reactor volume and jacket type. A 100-liter glass-lined reactor with a mechanically chilled jacket is a different capability from a 5-liter flask in a dry ice bath.
2. Documented internal temperature under load. Jacket set-point is not internal temperature. Ask what the internal probe reads during a charged exotherm.
3. Longest hold time at temperature. Some routes need nine hours at minus 70 degrees Celsius. A system that touches minus 78 and drifts back to minus 50 will not deliver those routes.
4. Cooling supply. Mechanical chiller, liquid nitrogen, or dry ice and solvent. Liquid nitrogen and mechanical chillers scale predictably. Dry ice baths do not scale past small vessels without a large labor cost.
5. Addition control. Slow, subsurface, temperature-controlled addition of a pyrophoric reagent is a different operation from pouring it in. Ask about metering pumps and subsurface dip tubes.

What It Costs If You Get It Wrong

A cryogenic step attempted with inadequate temperature control typically fails in one of two ways: the yield collapses, or the impurity profile changes so the downstream purification stops working. Either way you lose the batch. Practical cost at kilogram scale is four to eight weeks of schedule plus the material, and often a route change if the supplier decides the step cannot be run in their equipment. We cover the economics separately in why cryogenic chemistry costs what it does.

High-Pressure Hydrogenation

High-pressure hydrogenation is catalytic reduction with hydrogen gas above atmospheric pressure, typically 5 to 100 bar, in a rated pressure vessel with an appropriate hydrogen handling classification.

When Your Molecule Needs It

Hydrogenation appears in most routes at least once: nitro to amine, alkene or alkyne reduction, benzyl or Cbz deprotection, reductive amination, nitrile to primary amine, and aromatic ring saturation. Low pressure covers a lot of that. The pressure requirement climbs when you are reducing a nitrile, saturating an aromatic ring to a saturated heterocycle, or running an asymmetric hydrogenation where enantioselectivity depends on pressure.

Saturated nitrogen heterocycles are the common driver. Building blocks in our piperidines and piperazines catalog are frequently made by pyridine reduction, which typically demands elevated pressure and forcing conditions. A fluorinated example such as 4,4-Difluoropiperidine (CAS 21987-29-1) shows the compounding problem: the fluorines change both the reduction behavior and the stability of the product amine, so conditions optimized on the parent piperidine do not transfer.

What to Ask a Supplier to Prove It

• Vessel volume and maximum rated pressure, at your intended scale. A 300 mL Parr bomb rated to 100 bar is not a kilogram capability.
• Hydrogen supply and area classification. Cylinder manifolds, bulk hydrogen, or generated hydrogen, and whether the room is rated for the volumes involved. This is a facility question, not a chemistry question, and it is where domestic capability thins out fastest.
• Catalyst handling. Pyrophoric catalyst charging, filtration of spent catalyst, and metals removal to acceptable residual levels. Ask what their typical residual palladium is after workup and how they measure it.
• Asymmetric hydrogenation experience specifically, if that is your step. Chiral ligand screening is a distinct skill and a distinct cost. Owning a pressure reactor does not mean anyone there has run a rhodium- or ruthenium-catalyzed asymmetric reduction.
• Metals analysis. ICP-OES for residual catalyst is the standard method. Confirm it is in house rather than sent out, which adds a week per cycle.

The detailed interrogation list is in high-pressure hydrogenation capability questions.

What It Costs If You Get It Wrong

Under-specified pressure capability shows up as an incomplete reduction that looks like a yield problem. You lose a cycle finding out, and each hydrogenation cycle at scale is one to three weeks including analysis. Worse is the residual metals failure — material that passes purity by HPLC and fails on ICP-OES late, sometimes after you have committed it downstream. Budget six to ten weeks of recovery if a metals specification is missed at kilogram scale.

Fluorination

Fluorination is the introduction of fluorine or fluorine-containing groups into an organic molecule, and it is the capability area with the widest gap between what is claimed domestically and what is routinely available.

When Your Molecule Needs It

Roughly a fifth to a third of small-molecule drugs approved in recent years contain fluorine, so this is not a niche requirement. Fluorine blocks metabolic oxidation at a specific position, modulates the pKa of a nearby amine, and often improves membrane permeability. Your route needs fluorination capability only if you cannot buy the fluorinated building block, which is increasingly the deciding question — much of the practical answer is buying the fragment rather than making the bond.

Our fluorinated compounds catalog exists largely because of that calculation. 3-Trifluoromethyl Pyridine (CAS 3796-23-4) is far cheaper to purchase than to make, because the trifluoromethyl group on a pyridine ring is installed industrially under conditions no discovery-scale CRO should attempt. The same holds for 4-Fluoroindole (CAS 387-43-9) and most simple fluorinated aromatics.

The Three Tiers of Fluorination Capability

Tier	Chemistry	Domestic availability
Tier 1	Nucleophilic displacement with KF or CsF, and DAST-class deoxofluorination on activated substrates	Broad — most CROs can do this
Tier 2	Electrophilic fluorination with Selectfluor or NFSI, difluoromethylation, late-stage C–H fluorination	Moderate — ask for specific worked examples
Tier 3	Anhydrous HF, elemental fluorine, halogen exchange at temperature, industrial trifluoromethylation	Narrow — a small number of specialist facilities

Most buyers need Tier 1 or Tier 2 and can source Tier 3 output as a purchased building block. Trouble arises when a buyer assumes a supplier claiming ‘fluorination’ covers Tier 3, and only discovers otherwise after the quote is signed.

What to Ask a Supplier to Prove It

Ask which fluorinating reagents they hold and handle routinely, and whether they have run the specific class of transformation your step needs. Ask about waste handling — fluoride waste streams have real disposal requirements, and a supplier who has not thought about it has not run much of this chemistry. Ask about analytical support: fluorine-19 NMR is essential for confirming regiochemistry on polyfluorinated products, and a facility doing serious fluorination work will have it available without discussion.

What It Costs If You Get It Wrong

Selectivity is the cost. A fluorination that goes to the wrong position or over-fluorinates gives a mixture that is often extremely difficult to separate, because regioisomeric fluorinated compounds can be nearly identical chromatographically. That is a lost batch plus a method development project. Assume eight to sixteen weeks of recovery, and expect the honest answer to be to buy the building block instead.

Cross-Coupling: Suzuki, Buchwald and Relatives

Cross-coupling forms carbon–carbon and carbon–nitrogen bonds using a palladium or nickel catalyst, and it is the most widely available capability on this map — which creates its own failure mode.

When Your Molecule Needs It

Nearly every modern medicinal chemistry route uses at least one coupling. Suzuki–Miyaura joins an aryl halide to a boronic acid or ester. Buchwald–Hartwig makes the aryl carbon–nitrogen bond. Sonogashira, Negishi, Heck and Stille fill the remaining cases. If your target is a biaryl, a heteroaryl amine, or an N-arylated saturated heterocycle, you are coupling.

The coupling partners come from two catalog families. Halides and pseudohalides sit in our halogenated compounds catalog — 3-Iodopyridine (CAS 1120-90-7) is a workhorse, iodide being more reactive and better behaved than the corresponding chloride in most systems. Boron partners sit in our boronic acids catalog; 4-Bromophenylboronic acid (CAS 5467-74-3) is the classic differentially reactive partner that lets you couple once and keep a handle for a second coupling. Our deeper treatment of that chemistry is in boronic ester synthesis for drug discovery.

What to Ask a Supplier to Prove It

Because everyone can run a Suzuki coupling at 50 milligrams, the questions have to be about scale and about the difficult variants:

1. Ligand library. Which phosphines do they stock? A group holding only triphenylphosphine and one Buchwald ligand will struggle with hindered or electron-rich substrates.
2. Screening capacity. Can they run a 24- or 96-well catalyst and base screen, and how fast? This is where combinatorial and automated synthesis capability changes the timeline materially — a parallel screen turns a three-week optimization into three days.
3. Degassing and inert transfer at scale. Oxygen kills palladium catalysis. Ask how they degas a 100-liter reactor and how they charge catalyst under inert atmosphere.
4. Palladium removal. Residual palladium specifications for pharmaceutical intermediates are typically in the single-digit parts per million range. Ask which scavengers they use and whether ICP-OES is in house.
5. Boronic acid stability handling. Protodeboronation is the standard failure. Ask how they store and assay boronic acids on receipt, not just what the certificate of analysis said at the point of manufacture.

What It Costs If You Get It Wrong

Coupling failures are usually recoverable but expensive in cycles. Each failed optimization round at kilogram scale costs one to three weeks. The genuinely costly failure is metals: material that passes every other specification and fails on palladium at the end, forcing a repurification campaign or a rerun. That is four to eight weeks and a batch of expensive intermediate.

Chiral Synthesis and Resolution

Chiral capability means producing a single enantiomer to a defined enantiomeric excess, and proving it with a validated method. There are three routes to it and they are not interchangeable.

The Three Approaches

Asymmetric synthesis builds the stereocenter selectively using a chiral catalyst, auxiliary or reagent. Most efficient when it works, most development-intensive to get there. Chiral resolution makes the racemate and separates it — classical diastereomeric salt crystallization, enzymatic resolution, or preparative chiral chromatography. Simpler to develop, but it caps theoretical yield at 50 percent unless you can recycle or racemize the unwanted enantiomer. Chiral pool starts from a naturally occurring enantiopure material and carries the stereocenter through the sequence. Cheapest when a suitable starting material exists.

For many discovery-stage programs the practical answer is to buy the enantiopure fragment. (S)-2-Methylpyrrolidine (CAS 59335-84-1) is a good example — resolving it yourself is a project, and buying it is a purchase order.

What to Ask a Supplier to Prove It

• Which of the three approaches do they propose, and why that one for your substrate?
• Chiral analytical method. Do they have a validated chiral HPLC or SFC method for your compound class, or does one need developing? Method development is commonly four to eight weeks on its own and is routinely omitted from quoted timelines.
• Preparative separation in house. Analytical chiral HPLC and preparative chiral separation are different equipment. Ask which they have and at what throughput.
• Enantiomeric excess measured against what. Two suppliers can both report 99 percent enantiomeric excess against different methods with different limits of detection. Align on method before you compare material.
• Racemization risk downstream. Ask whether they have checked stereochemical integrity at the end of the sequence, not only immediately after the chiral step.

What It Costs If You Get It Wrong

Chiral failures are the most expensive on this map because they are often discovered late. If the enantiomeric excess is wrong and nobody had a method sensitive enough to see it, you can carry the error through several steps. Recovery is a resolution development project on top of a rerun, commonly three to six months at kilogram scale. This is why chiral steps deserve the most scrutiny in supplier selection, a theme we develop in how to choose a custom synthesis CRO.

Heterocycle Construction

Heterocycle construction means building the ring system rather than decorating a purchased one, and it is the least standardized capability area because every ring class has its own conditions.

When Your Molecule Needs It

You build the ring when you cannot buy it. That is the whole test. Common cores — pyridine, pyrimidine, indole, imidazole, pyrazole, piperidine, morpholine — are almost always cheaper to purchase than to construct, which is what our heterocyclic compounds catalog is for. Construction becomes necessary for unusual substitution patterns, fused systems, and the strained and spirocyclic scaffolds that have become popular for escaping flat aromatic chemical space.

Strained ring systems deserve their own note. Azetidines, oxetanes and bicyclic amines are attractive because they are three-dimensional and metabolically robust, and they are difficult because ring strain makes them reactive under conditions that leave a piperidine untouched. 1-BOC-3-Iodoazetidine (CAS 254454-54-1) is a widely used entry point precisely because building the azetidine ring is harder than functionalizing a purchased one. Related chemistry appears in our oxetane synthesis and spirocyclic and bicyclic amine synthesis discussions.

The Protecting Group Question

Heterocycle work is protecting group work. The tert-butoxycarbonyl group is the default for nitrogen, which is why our BOC-protected compounds catalog is one of the more heavily used hubs on the site. Ask a supplier how they handle BOC deprotection at scale — the gas evolution from acidic deprotection is a real process safety consideration in a large reactor, and a group that has only done it on the bench may not have thought about pressure relief.

What to Ask a Supplier to Prove It

Ask for a named ring-forming reaction they have run at your scale — a Fischer indole, a Hantzsch, a Paal–Knorr, a specific cyclocondensation. Ask about the workup, because heterocycle syntheses frequently produce water-soluble products that are difficult to isolate, and the isolation is often harder than the reaction. Ask about chromatography capacity: if the answer is ‘we would purify by column,’ find out the largest column they run and how much material it handles per pass.

What It Costs If You Get It Wrong

Ring construction that fails typically fails on isolation rather than on the bond-forming step. You get the product but cannot get it out of the aqueous phase, or cannot separate it from a closely related regioisomer. That is two to six weeks per iteration and it can consume expensive precursor with nothing to show for it.

Flow Chemistry

Flow chemistry runs a reaction continuously through a tube or channel reactor rather than in a batch vessel, and its value is specific rather than general.

When Your Molecule Needs It

Flow earns its place in four situations. First, when the chemistry is dangerous in batch — a strongly exothermic reaction, a diazo or azide intermediate, a nitration — because the reacting volume at any instant is small enough that a runaway is contained. Second, when the intermediate is unstable and must be generated and consumed within seconds. Third, when heat or mass transfer limits selectivity, since a tube reactor has far more surface area per unit volume than a tank. Fourth, when scale-up by batch would require a vessel you do not have, because flow scales by running longer rather than by running bigger.

Flow is not automatically better. For a well-behaved reaction with a long residence time and a heterogeneous slurry, batch is simpler, cheaper and easier to clean.

What to Ask a Supplier to Prove It

Ask what they have actually run in flow, not what their system is rated for. Specific questions: reactor type and volume, pressure and temperature range, whether they can handle solids or slurries (most systems cannot, and this eliminates many real reactions), inline analytical monitoring, and total throughput per day at your residence time. Ask how they transferred a batch process to flow and what changed — a group with genuine flow experience always has a story about a blocked reactor.

What It Costs If You Get It Wrong

The usual failure is not a bad batch, it is a stalled project. A supplier who proposes flow for a reaction with a precipitating product spends four to eight weeks discovering the reactor blocks, then reverts to batch. The cost is schedule and development time, rarely the material itself.

Scale Transitions: Milligram to Multi-Ton

Scale transition is a distinct capability from any individual reaction type, and it is where most domestic projects actually break — not because a step cannot be run, but because it cannot be run the same way a hundred times larger.

What Changes at Each Transition

Transition	What breaks first	What it needs
mg to g	Purification method; chromatography stops being practical	Crystallization or distillation development
g to 100 g	Heat transfer; exotherms that vented on the bench now matter	Calorimetry, controlled addition, larger reactor
100 g to kg	Reagent handling and workup volumes; solvent quantities become a cost and safety issue	Process safety review, solvent recovery, engineering controls
kg to multi-ton	Everything economic; cost of goods and waste streams dominate	Route redesign, catalyst recycling, continuous processing

The most common surprise is the first one. A discovery chemist who purifies everything by silica column has a route that does not exist at kilogram scale, because nobody runs a 40-kilogram silica column. Developing a crystallization is a real project — typically two to six weeks — and it is often the single largest hidden line item in a first scale-up quote. Our milligram to multi-ton and scale-up challenges posts cover the mechanics in more depth.

What to Ask a Supplier to Prove It

Ask what their largest reactor is and, separately, what their largest routinely used reactor is. Those are frequently different numbers. Ask whether process safety assessment — reaction calorimetry, thermal stability screening — is in house or subcontracted. Ask what happens at their ceiling: does the project transfer to a partner facility, and have they done that transfer before? A supplier who is honest about an upper limit and has a documented handoff path is more valuable than one who claims a ceiling they have never approached.

Where Capability Genuinely Ends

Most domestic custom synthesis CROs are strong from milligram to tens of kilograms. Above that you are in contract manufacturing rather than custom synthesis, which is a different business with different economics and usually a different facility. The distinction matters when you are choosing a partner for a molecule you expect to scale, and it is covered in the CRO versus CDMO decision framework.

Realistic Domestic Lead Times by Scale

Lead times below assume a route that has already been demonstrated somewhere and a supplier with the capability in house. Add development time on top for anything else.

Scale	Known route	Route development required
1 mg to 1 g	2 to 6 weeks	6 to 14 weeks
1 g to 100 g	4 to 8 weeks	10 to 20 weeks
100 g to 1 kg	6 to 12 weeks	14 to 26 weeks
1 kg to 10 kg	3 to 6 months	6 to 12 months
Multi-ton	9 to 18 months	18 months and up

Three adjustments apply. Add two to six weeks for any step requiring cryogenics, high-pressure hydrogenation or a chiral separation not already developed for your compound class. Add four to eight weeks if a chiral analytical method must be developed and validated. Add four to twelve weeks if the material is GMP, because documentation, qualification and release testing run on their own clock regardless of how fast the chemistry goes.

These are working ranges, not guarantees. They vary by facility, by queue position, and by how complete your specification is on day one. Pricing follows the same drivers, which we break down in custom synthesis pricing: what drives your quote.

Building Your Own Capability Requirement Sheet

Before you contact a supplier, write down what your route actually needs. One page, five columns:

1. Step number and transformation — what bond is being made or broken
2. Capability required — cryogenic, high pressure, fluorination, coupling, chiral, ring construction, flow
3. Scale at that step — accounting for yield losses downstream
4. Criticality — does the whole route fail if this step fails, or is there an alternative
5. Verification question — the specific thing you will ask a supplier to prove they can do it

Send that sheet with your request for quote. Two things happen. Suppliers who cannot do a step tend to say so rather than quoting around it, because the question is specific enough that hedging is visible. And the quotes you get back become comparable, since everyone is pricing the same defined scope rather than their own interpretation of a structure drawing.

The sourcing context for all of this — tariffs, the BIOSECURE Act, and the concentration risk that makes domestic capability worth paying for — is covered in the BIOSECURE Act and your chemical supply chain. For external reference, the FDA drug establishment registration database confirms facility registration status, the ICH quality guidelines define the documentation standards a qualified supplier should already meet, the EPA TSCA inventory governs whether a substance can be manufactured domestically at commercial scale, and the NIST Chemistry WebBook is a reliable free source for the physical property data a process safety review will need.

ChemContract Research has operated US-based custom synthesis from Huntington Beach, California since 2000, covering milligram to multi-ton scale with cryogenic chemistry to minus 78 degrees Celsius, high-pressure hydrogenation, fluorination, flow chemistry, and chiral synthesis and resolution in house. Our contract R&D group handles route development when the published sequence will not scale, and our catalog of 7,000-plus research chemicals covers the building blocks worth buying rather than making. Send us the route and mark the hard step — contact us and we will tell you plainly what we have run that resembles it, with a quote back within 24 hours.

Frequently Asked Questions

What does US-based custom synthesis capability actually mean?

It means a domestic facility can execute the specific unit operations your route requires at your target scale, with staff who have run comparable chemistry. Capability is the combination of equipment, demonstrated experience, and current staffing. An equipment list alone is not capability, because a reactor rated to minus 78 degrees Celsius does nothing without a chemist who has run a lithiation in it.

Which chemistry types are hardest to source domestically?

Selective fluorination, high-pressure hydrogenation above 50 bar at multi-kilogram scale, and preparative chiral separation are the three most common domestic bottlenecks. Cryogenic chemistry and cross-coupling are widely available at gram to kilogram scale. Nitration, azide chemistry and Grignard work at scale are also thinner domestically than buyers expect.

How do I verify a CRO can really run cryogenic chemistry?

Ask for the reactor volume, the minimum documented internal temperature under load, how cooling is supplied, and the longest hold time they have run at that temperature. Then ask for a redacted batch record of a comparable low-temperature reaction. Jacket set-point is not internal temperature, and a bath that reaches minus 78 degrees Celsius empty may only hold minus 55 degrees Celsius with a charged, exothermic reactor.

What are realistic domestic lead times for custom synthesis?

For a known route: milligram to gram in two to six weeks, 100 grams to 1 kilogram in six to twelve weeks, and multi-kilogram in three to six months. Add four to twelve weeks if route development is required, and add more for any step needing cryogenics, high-pressure hydrogenation or a chiral separation that has not yet been developed.

Is domestic custom synthesis more expensive than offshore?

On unit price at kilogram scale, usually yes. On total delivered cost the gap narrows substantially once tariffs, freight, quality failures, communication delay and the schedule value of a shorter feedback loop are included. For milligram and gram quantities on discovery timelines, domestic is frequently cheaper outright because iteration speed dominates the cost model.

When should I ask a supplier to develop a route versus quote an existing one?

Quote an existing route when you have a validated procedure and the supplier confirms every unit operation is in house. Ask for route development when any step depends on capability the supplier lacks, when the published route uses a reagent that does not scale, or when cost of goods at commercial scale would be unacceptable with the current sequence.